Travere Therapeutics, Inc. (TVTX)

Travere Therapeutics Revenue

Travere Therapeutics had revenue of $164.86M in the quarter ending September 30, 2025, with 162.11% growth. This brings the company's revenue in the last twelve months to $435.83M, up 114.22% year-over-year. In the year 2024, Travere Therapeutics had annual revenue of $233.18M with 60.55% growth.

• Revenue (ttm): $435.83M
• Revenue Growth: +114.22%
• P/S Ratio: 5.59
• Revenue / Employee: $1,132,016
• Employees: 385
• Market Cap: 2.49B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	233.18M	87.94M	60.55%
Dec 31, 2023	145.24M	35.78M	32.69%
Dec 31, 2022	109.46M	-22.38M	-16.97%
Dec 31, 2021	131.84M	-66.49M	-33.52%
Dec 31, 2020	198.32M	22.98M	13.11%
Dec 31, 2019	175.34M	11.09M	6.75%
Dec 31, 2018	164.25M	9.31M	6.01%
Dec 31, 2017	154.94M	21.35M	15.98%
Dec 31, 2016	133.59M	33.70M	33.74%
Dec 31, 2015	99.89M	71.69M	254.19%
Dec 31, 2014	28.20M	-	-
Dec 31, 2013	-	-	-
Dec 31, 2012	-	-	-